Possibility of Enlargement in Left Medial Temporal Areas Against Cerebral Amyloid Deposition Observed During Preclinical Stage
Neurodegenerative changes in the preclinical stage of Alzheimer’s disease (AD) have recently been the focus of attention because they may present a range of treatment opportunities. A total of 134 elderly volunteers who lived in a local community were investigated and grouped into preclinical and mi...
Main Authors: | Imabayashi, E. (Author), Ishibashi, K. (Author), Ishii, K. (Author), Kim, H. (Author), Kohda, N. (Author), Kojima, N. (Author), Sakata, M. (Author), Tago, T. (Author), Tokumaru, A.M (Author), Toyohara, J. (Author), Wagatsuma, K. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Assessing risk for preclinical β‐amyloid pathology with APOE, cognitive, and demographic information
by: Philip S. Insel, et al.
Published: (2016-01-01) -
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
by: Philip S. Insel, et al.
Published: (2017-05-01) -
Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
by: Young Chul Youn, et al.
Published: (2019-05-01) -
Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
by: Szu-Ying Lin, et al.
Published: (2019-12-01) -
Added value of amyloid PET in individualized risk predictions for MCI patients
by: Ingrid S. vanMaurik, et al.
Published: (2019-12-01)